Beta Drugs Limited (BDL) has announced the closure of its trading window for all Directors, Officers, Designated Employees, their immediate relatives, and others covered under the company's Code for Prevention of Insider Trading. The trading window will be closed from January 1, 2026, and will reopen 48 hours after the declaration of the Unaudited Financial Results for the quarter ended December 31, 2025. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and NSE circular NSE/CML/2019/11 dated April 2, 2019, regarding trading restriction periods. The company has informed the Listing Department of the National Stock Exchange of India Limited about this development.
